NEWGEN.NS stock jumped 17.19% to INR 622.90 on 20 Feb 2026, making Newgen Software Technologies Limited (NEWGEN.NS) the session’s most active name on the NSE with 61,297,141 shares traded. The move followed a low opening at INR 536.00 and a day high of INR 637.50, and came on volume roughly 101.91x the average, a clear sign of heavy intraday participation. Traders should weigh the jump against a trailing PE of 29.56 and a year high of INR 1,377.15 for context on valuation and risk.
Intraday move and liquidity: NEWGEN.NS stock
Newgen Software (NEWGEN.NS) closed at INR 622.90, up INR 91.35 or 17.19%, after trading between INR 526.05 and INR 637.50. Volume spiked to 61,297,141.00 versus an average of 601,495.00, producing a relative volume of 101.91 and placing the share among the market’s most active names on the NSE.
Advertisement
The market-cap stood at INR 87,696,929,292.00 and today’s order flow suggests short-term buyer interest. For sector context, the broader Technology complex showed weakness over recent months, amplifying the stock-specific nature of this surge source.
Fundamentals and valuation: NEWGEN.NS stock
Fundamentally Newgen reports EPS INR 21.07 and a trailing PE of 29.56, with a price-to-book of 5.51 and dividend per share INR 5.00. The company carries a strong current ratio of 4.37 and low debt-to-equity of 0.06, indicating balance-sheet strength despite a rich price multiple.
Revenue per share is INR 110.17 and return on equity is 20.43%, showing healthy profitability. Compare the current price to the 50-day average INR 716.90 and 200-day average INR 919.60, which signals the stock still trades below longer-term averages despite the rally.
Technical snapshot and momentum: NEWGEN.NS stock
Technicals show mixed signals: RSI at 36.10 and MACD histogram turned positive at 4.48, while ADX at 52.15 points to a strong trending move. Bollinger Bands sit at Upper 653.52 / Middle 559.73 / Lower 465.94, making INR 559.73 the mid-band pivot and INR 653.52 immediate technical resistance.
Money flow is stretched with MFI 90.81, suggesting short-term overbought pressure even as momentum readings signal heightened volatility. Traders should watch intraday levels and use the band structure for stop and target placement.
Meyka AI rates NEWGEN.NS with a score out of 100
Meyka AI rates NEWGEN.NS with a score out of 100: 77.44 | Grade: B+ | Suggestion: BUY. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.
Meyka AI’s forecast model projects a yearly target of INR 1,392.59 and a quarterly target of INR 762.65. Versus today’s INR 622.90, the yearly projection implies an upside of 123.56% while the monthly model of INR 558.73 implies a downside of 10.30%. Forecasts are model-based projections and not guarantees.
Catalysts and risks: NEWGEN.NS stock outlook
Near-term catalysts include the upcoming earnings announcement scheduled for 2026-04-30 and continued traction in enterprise content and process automation sales. Recent financial growth shows FY revenue growth of 19.54% and EPS growth near 25.03%, which supports revenue momentum.
Key risks: valuation is above sector averages (PB 5.51, P/S 5.65), days sales outstanding at 147.36 indicate receivable concentration risk, and the stock’s year high of INR 1,377.15 highlights prior higher valuation. Sector headwinds in Technology add macro sensitivity to stock-specific moves.
Trading note for most active session participants: NEWGEN.NS stock
Given today’s volume surge, active traders can treat INR 559.73 (BB middle) as short-term support and INR 653.52 as a first resistance. Immediate tactical price targets: INR 760.00 (near quarterly forecast INR 762.65) and a conservative stop below today’s low INR 526.05.
Liquidity is exceptional now — average volume 601,495.00 vs today 61,297,141.00 — but watch for rapid reversals and use position sizing accordingly. Internal and external news flow should guide size and duration of trades.
Final Thoughts
NEWGEN.NS stock’s 17.19% jump to INR 622.90 on 20 Feb 2026 was led by a dramatic volume surge that made it one of the session’s most active names on the NSE. Fundamentals show solid profitability (ROE 20.43%, EPS INR 21.07) and a strong balance sheet (current ratio 4.37, debt/equity 0.06), but valuation multiples (PE 29.56, PB 5.51) are stretched against recent sector weakness. Meyka AI’s model projects a yearly level of INR 1,392.59, implying 123.56% upside from today, while a short-term monthly projection sits at INR 558.73, implying a 10.30% downside. Active traders should respect intraday support at INR 559.73 and resistance near INR 653.52, and factor in the earnings date on 2026-04-30. Our coverage uses Meyka AI’s proprietary grade and forecast as part of a broader analytical view; these are model outputs and not investment guarantees. For real-time monitoring, use Meyka AI-powered market analysis platform alongside your own research.
Advertisement
FAQs
What drove the spike in NEWGEN.NS stock today?
Heavy volume and aggressive buying drove NEWGEN.NS stock higher; the share rose to INR 622.90 on 61,297,141 trades, far above the average. The move looks stock-specific amid mixed tech sector performance.
How does valuation look for NEWGEN.NS stock?
NEWGEN.NS stock trades at a trailing PE of 29.56 and PB of 5.51. Balance-sheet metrics are strong, but multiples are above sector averages, implying limited margin for error.
What are Meyka AI’s forecasts for NEWGEN.NS stock?
Meyka AI’s forecast model projects a yearly target of INR 1,392.59 and a quarterly target of INR 762.65. These imply potential upside and reflect model-based projections, not guarantees.
What short-term trade levels should I watch for NEWGEN.NS stock?
Watch intraday support at INR 559.73 (Bollinger middle) and resistance near INR 653.52. A conservative short-term target is INR 760.00, with a stop below INR 526.05.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
Advertisement
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)